Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Common Neurotransmission Recruited in (R,S)-Ketamine and (2R,6R)-Hydroxynorketamine–Induced Sustained Antidepressant-like Effects
Thu Ha Pham, Céline Defaix, Xiaoming Xu, et al.
Biological Psychiatry (2017) Vol. 84, Iss. 1, pp. e3-e6
Closed Access | Times Cited: 119

Showing 1-25 of 119 citing articles:

Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
Panos Zanos, Ruin Moaddel, Patrick J. Morris, et al.
Pharmacological Reviews (2018) Vol. 70, Iss. 3, pp. 621-660
Open Access | Times Cited: 942
Mechanisms of ketamine action as an antidepressant
Panos Zanos, Todd D. Gould
Molecular Psychiatry (2018) Vol. 23, Iss. 4, pp. 801-811
Open Access | Times Cited: 895
Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective
Kenji Hashimoto
Psychiatry and Clinical Neurosciences (2019) Vol. 73, Iss. 10, pp. 613-627
Open Access | Times Cited: 286
The neurobiology of depression, ketamine and rapid-acting antidepressants: Is it glutamate inhibition or activation?
Chadi G. Abdallah, Gerard Sanacora, Ronald S. Duman, et al.
Pharmacology & Therapeutics (2018) Vol. 190, pp. 148-158
Open Access | Times Cited: 198
The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects
Chadi G. Abdallah, Henk M. De Feyter, Lynnette A. Averill, et al.
Neuropsychopharmacology (2018) Vol. 43, Iss. 10, pp. 2154-2160
Open Access | Times Cited: 186
Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine
Danilo De Gregorio, Argel Aguilar‐Valles, Katrin H. Preller, et al.
Journal of Neuroscience (2020) Vol. 41, Iss. 5, pp. 891-900
Open Access | Times Cited: 185
Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor
Wei Yan, Lijia Chang, Kenji Hashimoto
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 559-573
Open Access | Times Cited: 180
Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites
Chun Yang, Jianjun Yang, Ailin Luo, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 163
Ketamine: A tale of two enantiomers
Luke A. Jelen, Allan H. Young, James Stone
Journal of Psychopharmacology (2020) Vol. 35, Iss. 2, pp. 109-123
Open Access | Times Cited: 163
Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies
Thu Ha Pham, Alain M. Gardier
Pharmacology & Therapeutics (2019) Vol. 199, pp. 58-90
Open Access | Times Cited: 154
Experimenters’ sex modulates mouse behaviors and neural responses to ketamine via corticotropin releasing factor
Polymnia Georgiou, Panos Zanos, Ta-Chung M. Mou, et al.
Nature Neuroscience (2022) Vol. 25, Iss. 9, pp. 1191-1200
Open Access | Times Cited: 99
NMDA Receptor Activation-Dependent Antidepressant-Relevant Behavioral and Synaptic Actions of Ketamine
Panos Zanos, Kyle A. Brown, Polymnia Georgiou, et al.
Journal of Neuroscience (2023) Vol. 43, Iss. 6, pp. 1038-1050
Open Access | Times Cited: 59
Targeting metaplasticity mechanisms to promote sustained antidepressant actions
Kyle A. Brown, Todd D. Gould
Molecular Psychiatry (2024) Vol. 29, Iss. 4, pp. 1114-1127
Open Access | Times Cited: 16
Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2R,6R)-hydroxynorketamine
Kenichi Fukumoto, Manoela V. Fogaça, Rong-Jian Liu, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 116, Iss. 1, pp. 297-302
Open Access | Times Cited: 160
Convergent Mechanisms Underlying Rapid Antidepressant Action
Panos Zanos, Scott M. Thompson, Ronald S. Duman, et al.
CNS Drugs (2018) Vol. 32, Iss. 3, pp. 197-227
Open Access | Times Cited: 154
Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments
Bashkim Kadriu, Laura Musazzi, Ioline D. Henter, et al.
The International Journal of Neuropsychopharmacology (2018) Vol. 22, Iss. 2, pp. 119-135
Open Access | Times Cited: 144
Antidepressant-relevant concentrations of the ketamine metabolite (2 R ,6 R )-hydroxynorketamine do not block NMDA receptor function
Eric W. Lumsden, Timothy A. Troppoli, Scott J. Myers, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 11, pp. 5160-5169
Open Access | Times Cited: 134
Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function
Ronald S. Duman, Ryota Shinohara, Manoela V. Fogaça, et al.
Molecular Psychiatry (2019) Vol. 24, Iss. 12, pp. 1816-1832
Open Access | Times Cited: 129
( 2R,6R )-hydroxynorketamine exerts mGlu 2 receptor-dependent antidepressant actions
Panos Zanos, Jaclyn N. Highland, Brent W. Stewart, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 13, pp. 6441-6450
Open Access | Times Cited: 128
Molecular Pharmacology and Neurobiology of Rapid-Acting Antidepressants
Todd D. Gould, Carlos A. Zarate, Scott M. Thompson
The Annual Review of Pharmacology and Toxicology (2018) Vol. 59, Iss. 1, pp. 213-236
Open Access | Times Cited: 117
(2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice
Junichi Yamaguchi, Hidetoh Toki, Youge Qu, et al.
Neuropsychopharmacology (2018) Vol. 43, Iss. 9, pp. 1900-1907
Open Access | Times Cited: 98
(2R,6R)-hydroxynorketamine rescues chronic stress-induced depression-like behavior through its actions in the midbrain periaqueductal gray
Dylan Chou, Hsien‐Yu Peng, Tzer-Bin Lin, et al.
Neuropharmacology (2018) Vol. 139, pp. 1-12
Closed Access | Times Cited: 94
Lateral Habenular Burst Firing as a Target of the Rapid Antidepressant Effects of Ketamine
Yihui Cui, Shaohua Hu, Hailan Hu
Trends in Neurosciences (2019) Vol. 42, Iss. 3, pp. 179-191
Closed Access | Times Cited: 79
Hydroxynorketamines: Pharmacology and Potential Therapeutic Applications
Jaclyn N. Highland, Panos Zanos, Lace M. Riggs, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 2, pp. 763-791
Open Access | Times Cited: 75
Ketamine for depression
Luke A. Jelen, James Stone
International Review of Psychiatry (2021) Vol. 33, Iss. 3, pp. 207-228
Closed Access | Times Cited: 70
Page 1 - Next Page

Scroll to top